← All organizations
Celerion
For profitWebsite ↗
Also known as: Celelion, Inc. | Celerion | Celerion, | Celerion Belfast | Celerion Belfast, Northern Ireland | Celerion, CRO | Celerion GB Ltd | Celerion GB Ltd. | Celerion Ltd | Celerion (MDS Pharma Services) | Celrion, Inc. | Drug Safety Solutions/Celerion
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2010Last known activity
Apr 4, 2025
Timeline
2010s
- Jan 1, 2010
Celerion— Founded
- Jan 11, 2016
Assign Clinical Research GmbH— Acquired
Drugs by trial phase (150 distinct, 153 trials)
Phase 3 (4 own, 5 via acquisition)
Phase 2 (13 own, 11 via acquisition)
Phase 1 (112 own, 3 via acquisition)
Indications
Studied for
- Acromegaly
- Acute Lung Injury
- Alzheimer Disease
- Aspergillosis
- Asthma
- Bronchiectasis
- Cardiomyopathies
- Chikungunya Fever
- Cocaine-Related Disorders
- Cystic Fibrosis
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Disruptive, Impulse Control, and Conduct Disorders
- Eunuchism
- Fibrosis
- Gastroenteritis
- Hematologic Neoplasms
- Hemoglobinopathies
- Hepatic Insufficiency
- Hypertension
- Hypertriglyceridemia
- Hyperuricemia
- Hypogonadism
- Idiopathic Pulmonary Fibrosis
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Juvenile
- Liver Diseases
- Liver Failure
- Malaria
- Melanoma
- Metabolism, Inborn Errors
- Methemoglobinemia
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Myelodysplastic Syndromes
- Pancytopenia
- Papillomavirus Infections
- Parkinson Disease
- Poliomyelitis
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pulmonary Alveolar Proteinosis
- Pulmonary Fibrosis
- Respiratory Aspiration
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Thrombosis
- Tuberculosis
- Virus Diseases
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT06971900CollaboratorPhase 2Apr 4, 2025
- NCT06677996OfficialPhase 1Nov 30, 2024
- NCT06597760CollaboratorPhase 1Oct 7, 2024
- NCT06597799OfficialPhase 1Aug 7, 2024
- NCT06625814CollaboratorPhase 1Jul 8, 2024
- NCT06356610CollaboratorN/AFeb 6, 2024
- NCT06179290CollaboratorN/AOct 2, 2023
- NCT05927649CollaboratorPhase 1Jul 11, 2023
- NCT05927649Overall official - principal investigatorPhase 1Jul 11, 2023
- NCT05909644CollaboratorPhase 1Jul 5, 2023
- NCT05909644Overall official - principal investigatorPhase 1Jul 5, 2023
- NCT05694533Overall official - principal investigatorPhase 1Mar 15, 2023
- NCT06691386CollaboratorN/AFeb 6, 2023
- NCT05623774Overall official - principal investigatorPhase 1Nov 30, 2022
- NCT05428696CollaboratorPhase 1Sep 12, 2022
Details
- Founded
- Lincoln, NE, US Jan 1, 2010
- Last known activity
- Apr 4, 2025